Verona Pharma price target raised to $160 from $76 at Piper Sandler

finance.yahoo.com/news/verona-pharma-price-target-raised-170831993.html

In This Article:
Piper Sandler raised the firm’s price target on Verona Pharma (VRNA) to $160 from $76 and keeps an Overweight rating on the shares. Verona Pharma remains one of Piper’s top 2025 picks, where Street expects OHTUVAYRE to reach blockbuster status in 2027 with meaningful…

This story appeared on finance.yahoo.com, 2025-06-24 17:08:31.
The Entire Business World on a Single Page. Free to Use →